Ajooni Biotech Limited

Ask AI

Key metrics

Price as of 2026-07-20

Stock price
₹4.20
Market cap
72 Cr
Stock P/E
14.7
P/B
0.81

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2025Jun 2025Sept 2025Dec 2025
Sales29 Cr31 Cr32 Cr59 Cr
Operating expenses (approx.)27 Cr30 Cr30 Cr55 Cr
EBITDA2 Cr1 Cr2 Cr3 Cr
OPM %8.0%4.3%5.2%5.7%
Other income1 Cr0.65 Cr0.15 Cr0.32 Cr
Interest0.06 Cr0.08 Cr0.17 Cr0.18 Cr
Depreciation0.38 Cr0.25 Cr0.25 Cr0.81 Cr
Profit before tax2 Cr1 Cr1 Cr2 Cr
Tax %19.2%23.9%24.4%30.1%
Net profit2 Cr0.78 Cr0.93 Cr2 Cr
EPS (₹)₹0.09₹0.02₹0.08₹0.10

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025TTM
Sales115 CrSign in for TTM
Operating expenses (approx.)109 CrSign in for TTM
EBITDA6 CrSign in for TTM
OPM %5.0%Sign in for TTM
Other income2 CrSign in for TTM
Interest0.33 CrSign in for TTM
Depreciation1 CrSign in for TTM
Profit before tax4 CrSign in for TTM
Tax %22.1%Sign in for TTM
Net profit3 CrSign in for TTM
EPS (₹)₹0.20Sign in for TTM
Dividend payout %0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025
Equity capital34 Cr
Reserves54 Cr
Borrowings
Other liabilities7 Cr
Total liabilities95 Cr
Fixed assets (net)11 Cr
CWIP0.29 Cr
Investments3 Cr
Other assets75 Cr
Total assets95 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025
Cash from operating activity-18 Cr
Cash from investing-17 Cr
Cash from financing25 Cr
Net cash flow-10 Cr
Free cash flow (OCF − Capex)-17 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025
ROCE %5.3%
ROE %3.8%
Debtor days
Inventory days90
Days payable
Cash conversion cycle90
Debt / equity
Current ratio12.86
Net debt / EBITDA-1.19